“Research has found that GLP-1s might help people stop smoking, reduce their cravings for opioids, lead them to consume fewer drinks.”
→ Read the source episode
Clinical trials demonstrate that GLP-1 medications reduce smoking cessation rates, opioid cravings, and alcohol consumption compared to placebo in statistically significant ways.
Ramon Mendez Gallain predicts wind can produce up to 40% of Uruguay's total electricity consumption annually.
Dhruv Kullar predicts that GLP-1s will usher in a new era of FDA-approved addiction treatments.
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.